Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Waisse Waissi"'
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 13, p 6825 (2021)
Pancreatic ductal adenocarcinoma is a devastating disease with a 5-year overall survival of 9% for all stages. Gemcitabine-based chemoradiotherapy for locally advanced pancreatic cancer is highly toxic. We conducted an in vitro study to determine whe
Externí odkaz:
https://doaj.org/article/cf2ee91ff3da45cc84e6e59d510c4451
Publikováno v:
Cancer Treatment Reviews. 118
In unresectable stage III non-small cell lung cancer (NSCLC), the standard of care for most fit patients is concurrent chemotherapy with normofractionated radiotherapy (NFRT), followed by durvalumab consolidation. Nevertheless, almost half of patient
Publikováno v:
Acta Oncologica. 61:720-729
Definitive external beam radiotherapy (EBRT) is an unusual treatment of unresectable soft-tissue sarcomas (STS). Recent technical innovations and physical advantages of particle therapies may improve results of this therapeutic option. The role of th
Autor:
Benoît Allignet, Paul Pou, Floriane Izarn, Isabelle Ray-Coquard, Jean-Yves Blay, Armelle Dufresne, Mehdi Brahmi, Amine Bouhamama, Pierre Meeus, Gualter Vaz, Francois Gouin, Alexandra Meurgey, Marie Karanian, Coralie Moncharmont, Waisse Waissi, Marie-Pierre Sunyach
Publikováno v:
The Oncologist.
IntroductionThe objective of this study was to evaluate the efficacy and safety of adjuvant radiotherapy (aRT) in patients with soft-tissue sarcoma (STS) re-excised after unplanned tumor resection (UPR).Materials and MethodsFrom 2000 to 2015, we retr
Publikováno v:
Cancers. 15:1643
Sarcomas gather a heterogeneous group of mesenchymal malignant tumors including more than 150 different subtypes. Most of them represent aggressive tumors with poor prognosis at the advanced stage, despite the better molecular characterization of the
Autor:
Benoît Allignet, Waisse Waissi, Xavier Geets, Armelle Dufresne, Mehdi Brahmi, Isabelle Ray-Coquard, Jean-Yves Blay, Amine Bouhamama, Pierre Meeus, Gualter Vaz, Francois Gouin, Coralie Moncharmont, Marie-Pierre Sunyach
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, Vol. 173, no.1, p. 55-61 (2022)
The use of definitive radiotherapy (dRT) in unresectable soft-tissue sarcomas (STS) is still controversial and recent data are scarce. We report clinical results of this therapeutic option. We retrospectively included STS patients treated between 200
Autor:
Sunyach Marie, Severine Prapan, Aurelie Bertaut, Marie Karanian, Gualter Vaz, Francois Guoin, Medhi Brahmi, Armelle Dufresne, Coralie Montcharmon, Waisse Waissi
Publikováno v:
Clinical Oncology and Research. :1-8
Background and Purpose: Limb sparing surgery and radiotherapy is the main treatment of patients harboring soft tissue sarcoma of the extremity. There is limited data regarding the prognostic impact of histologic response after pre-operative radiother
Autor:
Amine Bouhamama, Alexandra Meurgey, François Gouin, Pierre Meeus, Marie Karanian, Waisse Waissi, Marie-Pierre Sunyach, Benoît Allignet, Coralie Moncharmont, Gualter Vaz, Séverine Prapant
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 47(12)
Background Evaluation of response to neoadjuvant radiotherapy (NART) does not consider soft tissue sarcoma (STS) heterogeneity. We aimed to investigate radiological and pathological response of 4 major histotypes. Methods Extremity or trunk STS patie
Autor:
Georges Noël, Hélène Burckel, D. Jarnet, Anaïs Nicol, Waisse Waissi, Matthieu Jung, Marc Rousseau
Publikováno v:
Cancers
Cancers, MDPI, 2021, 13 (3), pp.527. ⟨10.3390/cancers13030527⟩
Volume 13
Issue 3
Cancers, 2021, 13 (3), pp.527. ⟨10.3390/cancers13030527⟩
Cancers, Vol 13, Iss 527, p 527 (2021)
Cancers, MDPI, 2021, 13 (3), pp.527. ⟨10.3390/cancers13030527⟩
Volume 13
Issue 3
Cancers, 2021, 13 (3), pp.527. ⟨10.3390/cancers13030527⟩
Cancers, Vol 13, Iss 527, p 527 (2021)
Over the past few years, studies have focused on the development of targeted radiosensitizers such as poly(ADP-ribose) polymerase inhibitors. We performed an in vivo study and a whole-transcriptome analysis to determine whether PARP inhibition enhanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d988463560f8dfd1a248d6f5bea42a12
https://hal.archives-ouvertes.fr/hal-03160783
https://hal.archives-ouvertes.fr/hal-03160783
Publikováno v:
Critical Reviews in Oncology/Hematology
Critical Reviews in Oncology/Hematology, Elsevier, 2020, 153, pp.103060-. ⟨10.1016/j.critrevonc.2020.103060⟩
Critical Reviews in Oncology/Hematology, Elsevier, 2020, 153, pp.103060-. ⟨10.1016/j.critrevonc.2020.103060⟩
Background Current research that combines radiation with targeted therapy may dramatically improve prognosis of pancreatic ductal adenocarcinoma (PDAC). We investigated preclinical outcomes of DNA repair inhibitor targeted therapy associated with rad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7736362f40fe0c3e22ca31b9bd6c8a1
https://hal.archives-ouvertes.fr/hal-03491443
https://hal.archives-ouvertes.fr/hal-03491443